anonymous
Guest
anonymous
Guest
What's the deal with this drug? Why didn't docs write for it? Help an Aralez rep out!
What's the deal with this drug? Why didn't docs write for it? Help an Aralez rep out!
Are you fukcing kidding me? Where do I start? Little managed care access, especially for Med D, and this is the age group for the drug. $300-350 a month doesn't work for them.
Triple anti-platelet? How do you spell excessive bleeding and pending lawsuits when that happens?
Weak data-only small, incremental benefit seen
No advocacy from a single national thought leader
No advocacy from a single teaching institution
No advertising in peer-respected journals
No discussions about it a national conferences
Not in any national guidelines
Addition of zontivity to aspirin and placid is a confounding factor
Other than that, there's nothing fucking wrong with the drug. We sold a little over 2 million and you dumb fucks bought it for what? 20 million? Good luck whack job
Because the studies are bogus and Drs don't believe in the product
Hey, I'm just a rep. I didn't buy the fucking thing! Maybe the problem was that you Merck fucks can't sell? We're launching this shit and we're gonna show you how it's done!
Alright then shit face. Lets come back in 6 months and you can tell us how it went. haha-cant wait to see this one
I delight in the pain and sleepless nights they will go through. They won't be able to sell squat
If you didn't try selling it off label, you weren't trying!
Yes, please! Looking forward to hearing from you this Fall so you can tell us Merck folks how you turned Zontivity around. Please show us how it's done.
Merck is still around???? Talk about a dinausaur company
Merck is still around???? Talk about a dinausaur company
A dinosaur company with countless blockbusters, billions in profit, and the trust of most docs in the field. Go home, Aralez shmucks. Your bullshit company can't play in the big leagues, and even cafepharma knows that and relegates you to the startup biotech boards. Lmao
i am not being mean or hateful, but neither could Merck....that's why they sold it.i cant get anyone interested in it! help!!!
Ha! Yeah, and you guys couldn't sell jack squat with all the money and power merck has behind them. We will sell it. Watch.
i cant get anyone interested in it! help!!!
Merck only targeted MI patients for Zontivity. AZ was expected to launch Brilinta for patients with PAD. Now, with Brilinta failing phase 3, Zontivity is the only FDA approved drug for patients with PAD. Any thoughts on success of this drug?
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204886s000lbl.pdf